Rare diseases
Investigational molecules
Locations
Back to France2 clinical trials in Vesoul, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Effect of Semaglutide in Patients with Type 1 Diabetes and Insulin Resistance
FranceComparing amoxicillin-clavulanate alone versus amoxicillin-clavulanate with ciprofloxacin for treating chemotherapy-induced fever in adult hematology patients
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on double diabetes, a complex condition where type 1 diabetes presents with insulin resistance features. Research explores the potential benefits of GLP1 agonist treatment in managing blood glucose levels.
The research aims to evaluate a 6-month treatment program's effectiveness in improving time spent within optimal glycemic ranges, potentially revolutionizing diabetes care approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
